Cambridge Investment Research Advisors’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $127K | Sell |
10,938
-15,628
| -59% | -$181K | ﹤0.01% | 3446 |
|
|
2025
Q1 | $232K | Sell |
26,566
-7,332
| -22% | -$64K | ﹤0.01% | 3089 |
|
|
2024
Q4 | $487K | Buy |
33,898
+2,498
| +8% | +$35.9K | ﹤0.01% | 2451 |
|
|
2024
Q3 | $709K | Buy |
+31,400
| New | +$709K | ﹤0.01% | 2130 |
|
|
2022
Q1 | – | Sell |
-1,458
| Closed | -$217K | – | 3314 |
|
|
2021
Q4 | $217K | Buy |
1,458
+48
| +3% | +$7.14K | ﹤0.01% | 2819 |
|
|
2021
Q3 | $205K | Buy |
1,410
+78
| +6% | +$11.3K | ﹤0.01% | 2796 |
|
|
2021
Q2 | $261K | Buy |
1,332
+69
| +5% | +$13.5K | ﹤0.01% | 2581 |
|
|
2021
Q1 | $229K | Sell |
1,263
-1,122
| -47% | -$203K | ﹤0.01% | 2500 |
|
|
2020
Q4 | $338K | Buy |
+2,385
| New | +$338K | ﹤0.01% | 2046 |
|